Furthermore, we showed that patients who were ApoE ε4 carriers and had history of dyslipidemia showed higher risk to convert to AD both compared to ApoEε4− groups and ApoE ε4+ without dyslipidemia patients. Here, APOE is linked to metabolic syndrome.